Journal ArticleOPEN ACCESS

Therapeutic potential of phosphoinositide 3-kinase inhibitors in rheumatoid arthritis

Japanese Journal of Clinical Immunology (2007) 30(5) 369-374
DOI: 10.2177/jsci.30.369
1Citations
Citations of this article
13Readers
Mendeley users who have this article in their library.

Abstract

Activation of PI3K is a key step of intracellular signaling involved in many cellular functions. PI3K inhibitors have shown anti-rheumatic effects on arthritis model in mice. PI3K is a potential therapeutic target of rheumatoid arthritis. © 2007, The Japan Society for Clinical Immunology. All rights reserved.

Author supplied keywords

Cite

CITATION STYLE

APA

Tamura, N., & Haruta, K. (2007). Therapeutic potential of phosphoinositide 3-kinase inhibitors in rheumatoid arthritis. Japanese Journal of Clinical Immunology, 30(5), 369–374. https://doi.org/10.2177/jsci.30.369

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free